HomeDrug Discovery

Drug Discovery

Intranasal powders – an exciting new dosage form for inhalation

The choice of dosage form is one of the first decisions facing drug development scientists. For most drugs, the answer is simple: formulate as...

Finding a Way Through the Life-threatening Detriments of Antimicrobial Resistance

The US Food and Drug Administration has officially approved AbbVie's EMBLAVEO™ (aztreonam and avibactam) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...

Finding a More Concrete Antidote for the Grave Alcohol Abuse Problem

atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, has officially announced positive topline results from Beckley...

Hot Topics